I am a Postdoctoral Scholar at Michigan State University, specializing in stem cell and cancer biology. I earned my Ph.D. in Biomedical Sciences from the University of Macau in 2021.
My research focuses on disease modeling and regenerative medicine. In the field of cancer biology, I developed a genetically engineered mouse model (GEMM) of NUT carcinoma via chromosome translocation to mimic the human genetic mechanism. In regenerative medicine, my work involves developing immune-evasive "off-the-shelf" cell therapies. To address immune rejection, I engineered B2M-knockout cells to co-express HLA-E and HLA-G, a strategy that simultaneously evades T-cell recognition and resists Natural Killer (NK) cell attacks.
Additionally, I am an Associate Member of the American Association for Cancer Research (AACR).
I am a Postdoctoral Scholar at Michigan State University, specializing in stem cell and cancer biology. I earned my Ph.D. in Biomedical Sciences from the University of Macau in 2021.
My research focuses on disease modeling and regenerative medicine. In the field of cancer biology, I developed a genetically engineered mouse model (GEMM) of NUT carcinoma via chromosome translocation to mimic the human genetic mechanism. In regenerative medicine, my work involves developing immune-evasive "off-the-shelf" cell therapies. To address immune rejection, I engineered B2M-knockout cells to co-express HLA-E and HLA-G, a strategy that simultaneously evades T-cell recognition and resists Natural Killer (NK) cell attacks.
Additionally, I am an Associate Member of the American Association for Cancer Research (AACR).